Compare Alcon AG (ALC) vs Xcel Energy Inc (XEL) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Alcon AG vs Xcel Energy Inc — how do they compare? Alcon AG trades at $66.64 (market cap $32.69B), while Xcel Energy Inc trades at $79.57 (market cap $50.36B). The key difference: Xcel Energy Inc is the larger of the two by market cap, and Xcel Energy Inc pays the higher dividend (2.94%). Which is the better fit depends on your goals.
| ALC | XEL | |
|---|---|---|
Market Cap | $32.69B | $50.36B |
Sector | Health | Utilities |
52-Week High | $92.22 | $83.91 |
52-Week Low | $62.02 | $67.56 |
Enterprise Value | $36.28B | $87.80B |
Dividend Yield | 0.54% | 2.94% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ALC trades at $66.87, down 4.01% on the day, amid a mixed technical and fundamental backdrop. The stock exhibits a bullish technical signal overall, with moving averages supporting a positive trend, while oscillators remain neutral. Fundamentally, revenue growth is steady, reaching $10.40 billion in 2025, though net income margin compressed to 7.7%. Recent news highlights product innovation, including a collaboration with RxSight for adjustable PCIOLs, signaling ongoing R&D investment. Analyst sentiment is predominantly positive, with a consensus price target of $86.00 implying significant upside.
The outlook for ALC is cautiously optimistic, driven by new product launches and strategic partnerships that may fuel growth. However, risks include competitive pressures, macroeconomic headwinds, and margin compression. With a P/E of 40.92, the valuation appears rich relative to historical norms, requiring strong earnings delivery to justify current levels. Investors should weigh robust analyst buy ratings against execution risks and market volatility.
Xcel Energy (XEL) trades at $80.67, down 1.57% on the day, with a bullish technical signal and strong analyst support (17 buy ratings). The stock shows steady revenue growth, with 2025 revenue at $14.67 billion and net income of $2.02 billion, though recent quarters saw mixed earnings results. A $60 billion capital expenditure plan through 2030 aims to capitalize on rising electricity demand from data centers and electrification trends.
The outlook is positive, supported by a consensus price target of $91.50, implying 13% upside. Key risks include regulatory pushback on rate hikes and high debt levels, with debt-to-assets at 41.64% in 2025. The dividend yield of 2.87% adds income appeal, but investors should monitor execution of the expansive capex plan and regulatory approvals.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →About Xcel Energy Inc
Xcel Energy manages utilities serving 3.7 million electric customers and 2.1 million natural gas customers in eight states. Its utilities are Northern States Power, which serves customers in Minnesota, North Dakota, South Dakota, Wisconsin, and Michigan
Read more on XEL →
